Good afternoon, everyone, and welcome to Solvay's Fourth Quarter and Full Year 2025 Earnings Call. I'm Geoffroy d'Oultremont, Head of Investor Relations. And with me today are our CEO, Philippe Kehren ...
How important is it to understand the natural history of disease before embarking on drug development? Annette Stemhagen of United BioSource Corporation discusses. Having an in-depth understanding of ...
Time and motion studies can be a useful way to gather real world evidence of a medical intervention's value. When the efficiency of a drug, medical device, or intervention is the outcome of interest, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results